Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CV Therapeutics
CV Therapeutics
CV Therapeutics rejects Astellas bid as loss widens
Marketwatch
Fri, 02/20/09 - 06:04 am
CV Therapeutics
Astellas
buyouts
earnings
CV Therapeutics will review Astellas offer again
Forbes
Thu, 01/29/09 - 09:55 am
CV Therapeutics
Astellas
buyouts
Astellas turns hostile in bid to buy CV Therapeutics
Pharma Times, UK
Wed, 01/28/09 - 07:45 am
CV Therapeutics
Astellas
buyouts
Astellas Proposes to Acquire CV Therapeutics for $16 Per Share in Cash
Yahoo
Tue, 01/27/09 - 09:41 am
Astellas
CV Therapeutics
buyouts
Looking for the Biotech Breakout
Seeking Alpha
Mon, 01/19/09 - 09:13 am
biotech
Biotech Ishares
Anadys
Cypress Bioscience
CV Therapeutics
Valeant Pharmaceuticals
Illumina
Biogen Idec
Life Technologies
Sequenom
Biomarin
Pages
« first
‹ previous
1
2